exchanged to give two chimeric HA molecules . These chimeric genes were used to construct recombinant vaccinia viruses expressing HA polypeptides . In one chimera the HA1 subunit is of H1 subtype and the HA2 subunit is of H3 subtype, and in the second chimera the HA1 subunit is of H3 subtype and the HA2 subunit is of H 1 subtype . Although these molecules do not exist naturally, they might be expected to form structures similar to naturally occurring HA molecules, and to behave in a similar manner in the infected cell . We have used the recombinant vaccinia viruses expressing chimeric HAs to prime mice and to test the specificity of any CTL response . In addition, cells infected with the recombinant vaccinia viruses have been tested as targets for HA-specific CTL .
Materials and Methods
Recombinant Vaccinia Viruses Containing HA Gene Chimeras. A full-length cDNA clone of the HA of human influenza A/NT/60/68 (H3 subtype) was constructed using the same method (7) as previously used for the HA of influenza A/PR/8/34 (HI subtype, Mount Sinai strain) . A Stu I restriction enzyme site was introduced into the cDNA clone of the A/PR/8/34 HA at the junction between the HA1 and HA2 subunits (17) using a 22-nucleotide-long mismatch oligonucleotide (18) to direct (19) the synthesis of the required mutation in the HA clone, inserted in M13mp8 . A Stu I site exists naturally in the equivalent position in the A/NT/60/68 HA gene (20) . The chimeric genes KG I I and KG 12 were constructed by ligating the required restriction fragments, isolated from agarose gels, with Hind III-Bam HI cut pKG5 plasmid (pKG5 [Gould, K ., unpublished data] is a derivative of pSVtkneo (7) , containing extra cloning sites) . In the case of the cDNA clone derived from A/NT/60/68, a partial Hind III digest was required to isolate the region encoding the entire HA I subunit because of the presence of an internal Hind III site . Similarly, a partial Bam HI digest was required for the isolation of the region encoding the HA2 subunit . Recombinant vaccinia viruses expressing the two chimeric HAs, the H1 subtype HA, and the H3 subtype HA were made by standard methods (21, 22) . The viruses were designated KG11-VAC, KG12-VAC, H1-VAC, and H3-VAC, respectively (Fig . 2) . Plasmid pGS62 (23) was used as the insertion vector, except for the construction of H1-VAC . In that case a new vector, pKG18 (Gould, K ., unpublished data), a derivative of pGS62 using the same vaccinia promoter for expression but with extra cloning sites, was used .
Immunoprecipitation . Confluent 25-cm z flasks of CV-1 cells were infected with vaccinia viruses at 30 PFU/cell . After 1 h at 37°C the innoculum was removed and replaced by methionine-free DME medium with 5% FCS . After a further 2 h at 37°C, 100 pCi of ["S]methionine was added to each flask . 1 .5 h later cells were harvested, washed once with PBS, and treated as described previously (7, 22) .
Cytotoxic T Cell Cultures In Vitro and CTL Assay. 3-6-mo-old female CBA mice (H-2 k ) were primed intravenously by injecting 10 7 PFU of recombinant vaccinia virus in 0 .1 ml of PBS into the tail vein (12) . 2 wk later their spleens were removed and the spleen cells were stimulated in vitro, as described previously (7) . Briefly, 1 .2 x 10 7 spleen cells were mixed with 2 x 10' syngeneic, 2,000 rad irradiated, A/PR/8/34 virus-infected feeder spleen cells in 15 ml of complete medium (RPMI 1640, 10% FCS, 5 x 10 -5 M 2-ME) . Cultures were harvested after 5 d at 37°C for testing in a standard 6-h 5 'Cr-release assay, with modifications for the use of adherent L929 target cells (H-2"), as described (7) . 2 x 10' target cells were infected with 0 .2 ml of infectious allantoic fluid or 2 x 10 7 PFU vaccinia virus and labeled with 125 ACi of "Cr for 90 min at 37°C . Percentage of specific chromium release was calculated as follows : Percent release = 100 x [(release by CTL) -
Each point was measured in duplicate against quadruplicate controls . Design and Construction of Chimeric HA Genes. A naturally occurring and unique Stu I restriction enzyme recognition site (Fig . 1) is present at the precise junction of the HA1 and HA2 subunits in the cDNA clone derived from the HA of influenza A/NT/60/68 (20) , and allowed us to design and construct artificial HA1-HA2 chimeras between influenza strains of H1 and H3 subtype. For the design (see below) to work, we first had to mutate a T -> C in the HA clone derived from influenza A/PR/8/34 to generate a Stu I site, using site-specific mutagenesis (see Materials and Methods) .
The design of the chimeras KG I I and KG 12 is shown in Fig. 2 and involves ligation of the relevant restriction fragments, isolated from the wild-type cDNA clone of the A/NT/60/68 HA and from the mutant HA clone of A/PR/8/34, with the plasmid pKG5 (see Materials and Methods) . Recombinant vaccinia viruses containing these chimeric HAs as well as the wild-type HAs were con- (Fig . 3) . The two chimeric HAs are recognized by antisera specific for the subtype of the HA I subunit. The slight difference in mobility of the intact HAs in the four tracks is probably related to differing extents of glycosylation, although all the HAs have the same number of potential glycosylation sites. The minor low molecular weight bands in the KG 1 1 and KG 12 tracks presumably reflect HA breakdown products, and their absence in the H1 and H3 tracks indicates decreased stability of the chimeric HAs. Expression of HA polypeptides on the cell surface was confirmed by FACS profiles of recombinant virus-infected cells stained with HA-specific mAbs (data not shown) .
Both Subunits of the HA Molecule Prime Mice for an HA Subtype-specific CTL Response . As expected, priming mice (see Materials and Methods) with control H1-VAC generates H1 subtype-specific polyclonal CTL that do not lyse H3 influenza virus-infected target cells (Fig . 4) . Priming with control H3-VAC and stimulating with H 1 influenza virus generates barely detectable influenza-specific CTL. In contrast, priming with vaccinia viruses expressing the two chimeric HAs (KGI I -VAC and KG 12-VAC) gives a strong H1-specific CTL response in both cases (Fig. 4) . These results clearly show that both the HAI and HA2 subunits of the A/PR/8/34 HA molecule contain determinants for generating CTL .
Both Subunits of the HA Molecule Are Targets for HA-specific Polyclonal CTL. Cells infected with each of the four recombinant vaccinia viruses were tested as targets for CTL generated by priming mice with H1-VAC (Fig. 5) . As expected from previous results (7, 14) , control H1-VAC CTL recognize H1-VAC-infected cells but only show a small amount of crossreaction with control H3-VAC-infected cells. Here we observe that both chimeric HA molecules (KGI 1 and KG12 targets) are recognized efficiently (Fig. 5) . In three different experiments, including that shown in Fig. 5 , lysis of targets expressing the HA2 subunit of HI subtype (i .e., KG12-VAC) was higher than lysis of targets expressing the HA2 subunit of H3 subtype (i.e., KG11-VAC).
Discussion
In this report we show that both subunits of the HA of influenza A/PR/8/34 (H I subtype) contain an antigenic determinant or determinants for CTL in CBA (H-2k) mice . This is in agreement with other work (15) that suggested that CTL derived from H-2' mice recognize up to four distinct antigenic sites within the HA molecule of A/JAP/305/57 (H2 subtype) . Recently, it has been shown (24) that the epitopes of influenza nucleoprotein recognized by class I MHC-restricted CTL can be defined with short synthetic peptides. These and other experiments (25, 26) suggest that class I-restricted recognition by CTL might involve processed antigenic fragments, as is the case for class II-restricted recognition of antigen by helper T cells (27) .
We have shown previously (14) that HA lacking an NH2-terminal signal peptide is efficiently recognized by CTL. This HA molecule is not transported to the cell surface but is rapidly degraded within the cytosol (14) , and thus it is unlikely that the sites recognized by CTL within the HA are dependent on the correct conformation of the molecule . Studies with cyanogen bromide fragments derived from the HA of influenza virus A/JAP/305/57 suggested that recognition by CTL could be localized to subpolypeptide regions (28) . In an extension of these experiments, two peptides, HA I (amino acids 181-204) and HA2 (amino acids 103-123), were found to generate murine secondary antiinfluenza CTL in vitro (29, 30) . Different work using engineered proteins produced in Escherichia coli suggested that the HA2 subunit of influenza virus A/PR/8/34 could stimulate the production of secondary CTL in vitro (31, 32) . However, this was only true if the HA2 polypeptide chain was fused to 81 amino acids of another influenza protein, the nonstructural protein NS1 . Other workers failed to show the induction of a secondary CTL response using purified HA2 subunit derived from influenza virus A/FPV/Rostock/34 (H7 subtype) (33) . Our results clearly show that for CBA mice there is an immunogenic site or sites for CTL within each subunit of the H 1 subtype HA molecule .
As it now seems that recognition by both CTL and helper T cells involves antigen processing (24, 26) , it is interesting to consider whether both types of T cell recognize the same sites within the HA molecule . A recent study (34) showed that there are determinants for proliferative T cells on both the HA I and HA2 subunits of H2 and H3 subtype HAs (34) . However, the three recognition sites for helper T cells within the A/PR/8/34 HA (H 1 subtype) that have been defined in detail so far are all in the HA1 subunit (35) . Clearly, further work using CTL clones is necessary to define precisely the sites within the A/PR/8/34 HA molecule that are recognized. Recently, it has been shown (36) that T cell antigenic sites tend to be amphipathic structures. This allows predictions to be made about the location of T cell recognition sites within proteins. The chemical synthesis of peptides corresponding to these regions and their use in chromiumrelease assays should allow precise identification of CTL recognition sites within the HA molecule.
